Gilbert O. Fruhwirth1, Bettina Weigelin2,3, Heike E. Daldrup-Link4, and Vladimir Ponomarev5 1Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Studies, King’s College London, London, UK 2Department of Preclinical Imaging and… Click to show full abstract
Gilbert O. Fruhwirth1, Bettina Weigelin2,3, Heike E. Daldrup-Link4, and Vladimir Ponomarev5 1Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Studies, King’s College London, London, UK 2Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Tübingen, Germany 3Cluster of Excellence iFIT (EXC 2180) “Image‐Guided and Functionally Instructed Tumor Therapies,”, University of Tuebingen, Tübingen, Germany 4Department of Radiology, Stanford University, Stanford, CA, USA 5Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA 2022
               
Click one of the above tabs to view related content.